Opendata, web and dolomites

cONCReTE SIGNED

DevelOpmeNt of Cancer RNA TherapEutics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 cONCReTE project word cloud

Explore the words cloud of the cONCReTE project. It provides you a very rough idea of what is the project "cONCReTE" about.

regulate    novels    concert    therapies    functional    vivo    identification    quality    cancer    expression    applicability    staff    molecular    biological    ing    personalized    clinical    academic    scientists    sme    form    governing    genes    exchange    ideal    inhibiting    ncrna    exposed    imaging    inter    accumulation    potentially    platform    aptamers    experts    epigenetics    monitor    safe    environments    animal    business    cell    biology    interdisciplinary    tumor    life    non    skills    patients    appropriately    drug    designed    transduction    types    progression    members    efficacy    tumors    teams    tools    synergetic    formulation    delivering    sectoral    models    reveal    oncology    appropriate    links    joint    toxic    derivatives    stable    malignant    complementary    codingrnas    contribution    network    competitiveness    education    training    performed    signal    innovative    international    spreading    oncogenic    molecules    qol    class    classes    cargoes    cells    therapeutic    ncrnas   

Project "cONCReTE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II 

Organization address
address: CORSO UMBERTO I, 40
city: NAPOLI
postcode: 80138
website: www.unina.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 2˙060˙800 €
 EC max contribution 2˙060˙800 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2019
 Funding Scheme MSCA-RISE
 Starting year 2020
 Duration (year-month-day) from 2020-05-01   to  2024-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II IT (NAPOLI) coordinator 165˙600.00
2    PERCUROS BV NL (LEIDEN) participant 174˙800.00
3    JENACELL GMBH DE (JENA) participant 128˙800.00
4    ASSOCIAZIONE HAND IN HAND IT (NEMI) participant 124˙200.00
5    CLINICA MEDITERRANEA SPA IT (NAPOLI) participant 124˙200.00
6    TACIT BIO INNOVATION LIMITED UK (SUTTON COLDFIELD) participant 119˙600.00
7    TECOBIOSCIENCES GMBH DE (LANDSHUT) participant 119˙600.00
8    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 110˙400.00
9    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 110˙400.00
10    FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS ES (BARCELONA) participant 110˙400.00
11    FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA ES (PAMPLONA) participant 110˙400.00
12    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 110˙400.00
13    PROGREDUM GMBH DE (KAISERSLAUTERN) participant 110˙400.00
14    RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN DE (BONN) participant 110˙400.00
15    UNIVERSITAET INNSBRUCK AT (INNSBRUCK) participant 110˙400.00
16    UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA RO (Cluj-Napoca) participant 110˙400.00
17    XENOPAT SL ES (HOSPITALET DE LLOBREGAT) participant 110˙400.00

Map

 Project objective

Non-codingRNAs (ncRNAs) represent a large class of molecules that in concert regulate the expression of genes involved in the key pathways governing cancer development and progression. They represent ideal targets for personalized cancer therapies and if appropriately designed they can provide specific, non-toxic and effective therapeutic tools. The identification of novel therapeutic ncRNAs and the design of their appropriate formulation is a key aspect for their clinical applicability. RISE- cONCReTE aims to form an international and inter-sectoral network of organizations working on a joint research programme on the development of a safe ncRNA-based drug. RISE- cONCReTE teams up experts in the fields of Molecular Oncology, Epigenetics, Signal transduction, Animal models, Therapeutic delivery and Imaging, business, and education. The participants will exchange skills, knowledge and staff members that will be exposed to synergetic and complementary research environments. RISE- cONCReTE will undertake an integrated approach to reveal novels functional links between ncRNAs and oncogenic pathways. We will: a) characterize novel classes of tumor-associated ncRNAs; b) investigate the impact of ncRNAs on key aspects of tumor cell biology; c) develop cargoes (e.g. aptamers) for delivering therapeutic ncRNA derivatives into specific cancer cell types. By using innovative in vivo imaging tools, we will monitor the accumulation of target ncRNAs in cancer cells and evaluate their biological efficacy in inhibiting the growth and spreading of malignant tumors. The resulting approaches will provide stable and effective tools thus potentially improving the quality of life (QOL) of the cancer patients. Further, the joint research and training programme of RISE- cONCReTE will be performed in academic institutions and SME to provide a unique interdisciplinary platform for scientists with a significant contribution to EU competitiveness.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CONCRETE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CONCRETE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

OPEN (2019)

Outcomes of Patients’ Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology

Read More  

RADON (2020)

Irradiation driven nanofabrication: computational modelling versus experiment

Read More  

FUNGLASS (2019)

FUNctional GLASS

Read More